Reports
Reports
Sale
The global biopreservation market reached a value of about USD 6.4 billion in 2023, driven by the growing demand for biobanking and regenerative medicines across the globe. The market is further expected to grow at a CAGR of about 14.4% in the forecast period of 2024-2032 to reach a value of around USD 21.5 billion by 2032.
Biopreservation is a process used to preserve bio-products such as stem cells, DNA, tissues, and organs. It is designed to maintain the effectiveness and functions of these products under varying conditions. Microarrays and predictive models, which have been developed along with API algorithms, are the technologies that cut the process's duration, cost, and complexity. Multiplex cellular imaging platforms are predicted to effectively explain disease progression and make suitable diagnoses and treatments. Biopreservation has become very popular in hospitals and labs because of the use of more products, funds from the government and partners, and many other research and development tasks, as well as the development of new products.
Rising Demand for Biobanking Drives Market Growth
The demand for storing biological samples for research and diagnostic purposes is booming. Biobanks are necessary for these samples' proper functionality, especially in massive population-based studies and clinical trials. The focus on precision medicine and individual healthcare approaches has strengthened the role of biobanks in genomic testing, biomarker discovery, and tailored treatments.
Continuous Advancements in Regenerative Medicine Boost the Biopreservation Market Demand
Regenerative medicine is becoming an essential part of the entire world's economy. Biopreservation is the main aspect that contributes to the continued vitality and usability of cells, tissues, and engineered constructs in both the present and future. Stem cells are commonly stored by cryopreservation methods such as freezing and vitrification for later use or other forms of treatment. Stem cell preservation protocols and cryoprotectants have been upgraded lately thus, the cells become stronger and more productive after the heating and cooling process ends.
Key Trends | Impact |
Expansion of the Biopharmaceutical Industry | The biopharmaceutical industry, which specializes in creating and manufacturing therapeutic proteins, antibodies, vaccines, and cell therapies, is rapidly growing. Their shelf stability and quality require biopreservation throughout the product’s life span. This has led to a high demand for preservation techniques owing to their vulnerability to different environmental factors. If biopharmaceutical products are cryopreserved or lyophilized, they will have increased shelf life and product quality through proper testing for efficacy and safety. |
Advancements in Cryopreservation Techniques | Enhancements in cryopreservation technology have positively enhanced the degree of biopreservation reliability. Techniques like vitrification and the application of cryoprotectants help to improve the successful rate of cells, tissues, and organs’ cryopreservation and decrease cell damage to a minimum during freeze and thaw procedures. |
Increasing Focus on Personalized Medicine | The trend towards targeted medicines is contributing to the growth of biopreservation solutions. Specific therapies require genetically tailored biological materials as constituents of individualized care delivery. These must be stored optimally to retain their efficacy. |
Emergence of Automated Biopreservation Systems | Automated systems in the process of biopreservation, such as robotics in the handling and controlling of temperature, are improving effectiveness with little or no human intervention. These systems provide stable and repeatable conditions for specimen storage, which is applicable for large-scale studies and biobanking. |
In April 2024 , Thermo Fisher Scientific announced the launch of the TSX Universal Series Ultra-Low Temperature (ULT) Freezers, which will offer 33% energy savings and the best possible performance. These freezers enable the Universal V Drive technology for temperature control, faster recovery times, universal voltage, and an expanded setpoint range. They are Energy Star® certified and produced in a zero-waste to landfill accredited facility, thus enabling lab sustainability. The TSX Universal Series is perfect for biopreservation, guaranteeing the durability and integrity of our biological samples.
In September 2023 , Avantor, Inc., one of the global providers of mission-critical products and services, collaborated with Tobin Scientific to manage end-to-end biopharmacy customer lab moves, research facilities, and sample relocation. The initiative's main goal is to provide temperature-specific logistics solutions to meet the uptick in demand, and it also ensures the safety and smooth travel of the required materials. The collaboration between Avantor and Tobin Scientific allows both short- and long-term storage solutions, which significantly decreases downtime and mocks temperature-controlled materials' Good Manufacturing Practice processes. Therefore, this process is significant for the protection of living tissues and the maintenance of the sample's homology throughout.
Market Breakup by Product Type
Market Breakup by Application
Market Breakup by End User
Market Breakup by Region
Biobank Application Expected to Hold the Largest Market Share
Based on the application, the market is divided into regenerative medicine, biobank, drug discovery, and others. Among these, biobanks are expected to lead the market share in the forecast period. Biobanks are specialized centers that are used for the storage and management of laboratory biological samples for research, clinical, or diagnostic purposes. They use biopreservation methodologies for long-term storage as well as usability. Biobanks are involved in research activities and multi-centre trials. Drug discovery applications also contribute to the demand for biopreservation, mainly because cell lines and primary cells are instrumental in screening, testing, and studying potential drugs.
Market Segmentation by Product Type is Projected to Experience Significant Growth
The market is segmented by product type into biopreservation equipment, biopreservation media and others. Among these biopreservation media is expected to dominate the market due to their pivotal function of keeping the cellular, tissue, and organ structures and capabilities intact and active during storage and transport. The large and expanding market for regenerative medicine, stem cell research, and personalized medicine has created the need for efficient and reliable preservation methods, thus propelling the biopreservation media segment.
Based on region, the market report is divided into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. Among these, North America is expected to have the largest market share, attributable to the developed healthcare system, extensively developed medical research laboratories, pharmaceutical organizations, and biotechnology companies. The region has a dense network of biobanks, such as government-supported biobanks and local biobanks, for the collection and preservation of various types of biospecimens for research and commercial purposes.
The Asia Pacific region is another major consumer of these technologies. It has a large population and a growing biopharmaceutical industry.
The key features of the market report include patent analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies are:
BioLife Solutions, Inc.
Founded in 1998 and headquartered in the United States, they include CryoStor® freeze media, which maintains high post-thaw cell viability and recovery, and HypoThermosol® for storage and transportation of cells, tissues, and organs at low temperatures. These solutions are vital for retaining the virginity and functionality of tissues, organs, and other biological items that are preserved.
Thermo Fisher Scientific Inc.
Established in 1956 and based in the US, the company provides CryoMed® freezing containers and a controlled-rate freezer for freezing and preserving several types of biological material. Thermo Fisher also offers controlled-temperature storage solutions such as ultra-low-temperature freezers for sample storage in biobanking and biomedical research.
Other companies include Exact Sciences Corporation, Simport Scientific Inc., ThermoGenesis Holdings, Inc., Lifeline Scientific, MVE Biological Solutions and Princeton CryoTech.
Kindly note that this only represents a partial list of companies, and the complete list has been in the report.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product Type |
|
Breakup by Application |
|
Breakup by End User |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Biopreservation Market Overview
3.1 Global Biopreservation Market Historical Value (2017-2023)
3.2 Global Biopreservation Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Biopreservation Market Landscape*
5.1 Global Biopreservation: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Biopreservation: Product Landscape
5.2.1 Analysis by Product Type
5.2.2 Analysis by Application
6 Global Biopreservation Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Biopreservation Market Segmentation (2017-2032)
7.1 Global Biopreservation Market (2017-2032) by Product Type
7.1.1 Market Overview
7.1.2 Biopreservation Equipment
7.1.3 Biopreservation Media
7.1.4 Others
7.2 Global Biopreservation Market (2017-2032) by Application
7.2.1 Market Overview
7.2.2 Regenerative Medicine
7.2.3 Biobank
7.2.4 Drug Discovery
7.2.5 Others
7.3 Global Biopreservation Market (2017-2032) by End User
7.3.1 Market Overview
7.3.2 Hospitals
7.3.3 Biobank
7.3.4 Research and Academic Institute
7.3.5 Others
7.4 Global Biopreservation Market (2017-2032) by Region
7.4.1 Market Overview
7.4.2 North America
7.4.3 Europe
7.4.4 Asia Pacific
7.4.5 Latin America
7.4.6 Middle East and Africa
8 North America Biopreservation Market (2017-2032)
8.1 North America Biopreservation Market (2017-2032) by Product Type
8.1.1 Market Overview
8.1.2 Biopreservation Equipment
8.1.3 Biopreservation Media
8.1.4 Others
8.2 North America Biopreservation Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Regenerative Medicine
8.2.3 Biobank
8.2.4 Drug Discovery
8.2.5 Others
8.3 North America Biopreservation Market (2017-2032) by End User
8.3.1 Market Overview
8.3.2 Hospitals
8.3.3 Biobank
8.3.4 Research and Academic Institute
8.3.5 Others
8.4 North America Biopreservation Market (2017-2032) by Country
8.4.1 United States of America
8.4.2 Canada
9 Europe Biopreservation Market (2017-2032)
9.1 Europe Biopreservation Market (2017-2032) by Product Type
9.1.1 Market Overview
9.1.2 Biopreservation Equipment
9.1.3 Biopreservation Media
9.1.4 Others
9.2 Europe Biopreservation Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Regenerative Medicine
9.2.3 Biobank
9.2.4 Drug Discovery
9.2.5 Others
9.3 Europe Biopreservation Market (2017-2032) by End User
9.3.1 Market Overview
9.3.2 Hospitals
9.3.3 Biobank
9.3.4 Research and Academic Institute
9.3.5 Others
9.4 Europe Biopreservation Market (2017-2032) by Country
9.4.1 United Kingdom
9.4.2 Germany
9.4.3 France
9.4.4 Italy
9.4.5 Others
10 Asia Pacific Biopreservation Market (2017-2032)
10.1 Asia Pacific Biopreservation Market (2017-2032) by Product Type
10.1.1 Market Overview
10.1.2 Biopreservation Equipment
10.1.3 Biopreservation Media
10.1.4 Others
10.2 Asia Pacific Biopreservation Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Regenerative Medicine
10.2.3 Biobank
10.2.4 Drug Discovery
10.2.5 Others
10.3 Asia Pacific Biopreservation Market (2017-2032) by End User
10.3.1 Market Overview
10.3.2 Hospitals
10.3.3 Biobank
10.3.4 Research and Academic Institute
10.3.5 Others
10.4 Asia Pacific Biopreservation Market (2017-2032) by Country
10.4.1 China
10.4.2 Japan
10.4.3 India
10.4.4 ASEAN
10.4.5 Australia
10.4.6 Others
11 Latin America Biopreservation Market (2017-2032)
11.1 Latin America Biopreservation Market (2017-2032) by Product Type
11.1.1 Market Overview
11.1.2 Biopreservation Equipment
11.1.3 Biopreservation Media
11.1.4 Others
11.2 Latin America Biopreservation Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Regenerative Medicine
11.2.3 Biobank
11.2.4 Drug Discovery
11.2.5 Others
11.3 Latin America Biopreservation Market (2017-2032) by End User
11.3.1 Market Overview
11.3.2 Hospitals
11.3.3 Biobank
11.3.4 Research and Academic Institute
11.3.5 Others
11.4 Latin America Biopreservation Market (2017-2032) by Country
11.4.1 Brazil
11.4.2 Argentina
11.4.3 Mexico
11.4.4 Others
12 Middle East and Africa Biopreservation Market (2017-2032)
12.1 Middle East and Africa Biopreservation Market (2017-2032) by Product Type
12.1.1 Market Overview
12.1.2 Biopreservation Equipment
12.1.3 Biopreservation Media
12.1.4 Others
12.2 Middle East and Africa Biopreservation Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Regenerative Medicine
12.2.3 Biobank
12.2.4 Drug Discovery
12.2.5 Others
12.3 Middle East and Africa Biopreservation Market (2017-2032) by End User
12.3.1 Market Overview
12.3.2 Hospitals
12.3.3 Biobank
12.3.4 Research and Academic Institute
12.3.5 Others
12.4 Middle East and Africa Biopreservation Market (2017-2032) by Country
12.4.1 Saudi Arabia
12.4.2 United Arab Emirates
12.4.3 Nigeria
12.4.4 South Africa
12.4.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Funding and Investment Analysis
14.1 Analysis by Funding Instances
14.2 Analysis by Type of Funding
14.3 Analysis by Funding Amount
14.4 Analysis by Leading Players
14.5 Analysis by Leading Investors
14.6 Analysis by Geography
15 Strategic Initiatives
15.1 Analysis by Partnership Instances
15.2 Analysis by Type of Partnership
15.3 Analysis by Leading Players
15.4 Analysis by Geography
16 Supplier Landscape
16.1 Market Share Analysis, By Region (Top 5 Companies)
16.1.1 Market Share Analysis: Global
16.1.2 Market Share Analysis: North America
16.1.3 Market Share Analysis: Europe
16.1.4 Market Share Analysis: Asia Pacific
16.1.5 Market Share Analysis: Others
16.2 BioLife Solutions, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisitions
16.2.5 Certifications
16.3 Thermo Fisher Scientific Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisitions
16.3.5 Certifications
16.4 Exact Sciences Corporation
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisitions
16.4.5 Certifications
16.5 Simport Scientific Inc.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisitions
16.5.5 Certifications
16.6 ThermoGenesis Holdings, Inc.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisitions
16.6.5 Certifications
16.7 Lifeline Scientific
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisitions
16.7.5 Certifications
16.8 Princeton CryoTech
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisitions
16.8.5 Certifications
16.9 MVE Biological Solutions
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisitions
16.9.5 Certifications
17 Global Biopreservation Market – Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.